“…Advancements in management of CDH (Doyle & Lally, ), extracorporeal membrane oxygenation (ECMO) and having the defect surgically repaired are among the clinical factors known to improve survival (Davis et al, ). There is further evidence that antenatal parameters such as observed‐to‐expected (O/E) lung‐to‐head ratio (LHR), the position of the liver and stomach and the O/E total fetal lung volume are also useful indicators of survival (Mayer et al, ; Morini, Goldman, & Pierro, ; Oluyomi‐Obi et al, ; Terui et al, ). However, these advances have only led to modest improvements in survival with survival rates remaining around 70% for the past two decades (Mah et al, ; McGivern et al, ).…”